Volume: 6 Issue: 3
Year: 2018, Page: 37-39,
Introduction : Diabetes mellitus is one of the most common metabolic disorder and leading cause of death and disability in the world. Magnesium deficiency can lead to development of diabetic complications such as nephropathy, retinopathy, thrombosis and hypertension. This is a cross sectional study designed to determine whether there is any association between serum magnesium concentration [Mg2+] and the rate of renal function deterioration in patients with diabetes mellitus type 2 (DM2).
Materials & Methods: A cross sectional study was done in randomly chosen 50 Type 2 diabetic patients without renal dysfunction,50 diabetic with renal dysfunction of age between 40 and 60 years, 50 non diabetic controls with age and sex matched attending our institute during November-February-2018 were included. All patients and controls underwent thorough clinical examination and estimation of serum Magnesium, FBS, PPBS, hemoglobin A(1C), urinary albumin creatine ratio(UACR), as well as history of hypertension and pharmacy profiles were retrieved.
Results: The mean serum magnesium levels among Type 2 DM with renal dysfunction , Type 2 DM without renal dysfunction and healthy controls were 0.795±0.199mg/dl, 1.319±0.103mg/dl, 2.33±0.28mg/dl respectively.
Conclusion: There was a significant reduction in serum Magnesium [Mg] levels in diabetics compared to the controls. Lower “Mg” is associated with a faster renal function deterioration rate in Type 2 DM patients.
Keywords: Diabetes mellitus(DM) , Hypomagnesaemia, urinary albumin Creatinine ratio(UACR), Magnesium(Mg)
1. King H, Aubert RE, Herman WH. Global burden of diabetes. Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21(9):1414-31.
2. Rude RK. Magnesium deficiency and diabetes mellitus. Causes and effects. Postgrad Med 1992;92:217–219, 222– 224.
3. Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care 2003;26:1147–1152.
4. Migdalis IN, Xenos K, Chairopoulos K, Varvarigos N, Leontiades E, Karmaniolas K. Ca(2+)-Mg(2+)-ATPase activity and ionized calcium in Type 2 diabetic patients with neuropathy. Diabetes Res Clin Prac t2000;49:113– 118.
5. De Valk HW, Hardus PL, van Rijn HJ, Erkelens DW. Plasma magnesium concentration and progression of retinopathy. Diabetes Care 1999;22:864–865.
6. Rodríguez-Morán M, Guerrero-Romero F. Low serum magnesium levels and foot ulcers in subjects with type 2 diabetes. Arch Med Res 2001;32:300–303.
7. A. Corsonello, R. Ientile, M. Buemi et al., “Serum ionized magnesium levels in type 2 diabetic patients with microalbuminuria or clinical proteinuria,” American Journal of Nephrology, 2000; 20(3): 187–192.
Kishan Reddy H, Venugopal B. Association of serum Magnesium levels with renal function in patients with diabetes mellitus type 2. A cross sectional study in rural population of North Telangana. Perspectives in Medical Research 2018; 6(3):37-39.